®

– Testocreme® is a new testosterone formulation
– 505(b)(2) regulatory pathway for clinical development
– Phase I clinical trial to evaluate

  • Lowest effective dosage
  • Pharmacokinetics
  • Safety

Regulatory

Following Phase I Clinical Study, Testocreme® will seek a strategic partner or potential acquirer.

Testosterone is an approved and marketed drug